RMD News: ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US - 4th Apr 2025, 4:28am

[annb0t]

ResMed launched NightOwl™, a home sleep apnea test that enhances user convenience with a small fingertip sensor and cloud data evaluation. Despite the broader market reacting negatively to new tariffs announced by President Trump—causing significant declines across major indexes like the Dow Jones and S&P 500—ResMed's stock remained relatively flat over the past week. The stable performance may reflect investor confidence in the potential of its innovative health solutions, contra...

>>> Read more: ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US